Rodman David Malcom

CIK 00016726592 companiesRADNOR, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001672659

Recent Transactions

50 trades

Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-20−416→ 5,834 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-20$15.44/sh+416→ 50,853 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-20$32.10/sh−416→ 50,437 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-12$1.08/sh+6,348→ 68,152 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-12$32.32/sh−6,348→ 61,804 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-12−6,348→ 38,092 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-09$33.27/sh−2,170→ 61,804 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-09−2,170→ 28,218 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-09$16.00/sh+2,170→ 63,974 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-05$34.83/sh−139,245→ 115,274 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-05$15.44/sh+10,121→ 107,347 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-05$14.25/sh+67,473→ 254,519 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-05−53,630→ 30,388 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-05−10,121→ 6,250 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-05$35.53/sh−53,470→ 61,804 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-05$1.08/sh+28,038→ 97,226 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-05−67,473→ 108,334 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-05−26,069→ 134,584 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-05$10.20/sh+26,069→ 133,416 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-05−28,038→ 44,440 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-05$16.00/sh+53,630→ 187,046 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-02−10,053→ 72,478 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-02−9,347→ 160,653 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-02$35.87/sh−70,037→ 69,188 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-02$1.08/sh+10,053→ 81,888 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-02−20,168→ 84,018 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-02$16.00/sh+20,168→ 115,032 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-02−24,193→ 175,807 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-01-02−3,629→ 16,371 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-02$10.20/sh+9,347→ 94,864 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-02$15.44/sh+3,629→ 85,517 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-02$14.25/sh+24,193→ 139,225 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-10-15$43.01/sh−10,369→ 71,155 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-09-15$35.90/sh−9,302→ 83,589 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-09-15$36.47/sh−2,065→ 81,524 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-08-13$12.93/sh−11,365→ 92,891 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-08-12$1.08/sh+6,349→ 104,256 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2025-08-12−6,349→ 82,531 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2025-07-14−6,349→ 88,880 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-07-14$1.08/sh+6,349→ 109,273 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-07-14$14.59/sh−11,366→ 97,907 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-06-13$14.60/sh−11,366→ 101,651 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2025-06-12−6,348→ 95,229 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-06-12$1.08/sh+6,348→ 113,017 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-05-14$15.29/sh−11,366→ 106,669 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-05-12$1.08/sh+6,349→ 118,035 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2025-05-12−6,349→ 101,577 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-04-14$1.08/sh+6,348→ 123,052 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-04-14$13.69/sh−2,966→ 120,086 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-04-14$14.83/sh−8,400→ 111,686 total

Companies

Recent Filings

Address

150 N. RADNOR CHESTER RD. SUITE F200

RADNOR, PA, 19087

View on SEC.gov